Feb. 4, 2008 - Lipomics Technologies, Inc., a privately held company that specializes in clinical diagnostic development, announced that it is engaged in a research collaboration with Joslin Diabetes Center.The collaboration will initially focus on two research programs. The first is a study on insulin resistant patients with a family history of type 2 diabetes. The primary objective is to identify predictive markers of disease that can be translated into blood based diagnostics.
The second study will focus on understanding the effects of gastric bypass surgery on insulin sensitivity. Both research programs originate from the laboratories of Mary Elizabeth Patti, MD, and Allison Goldfine, both Assistant Professors of Medicine, at Harvard Medical School and Investigators at Joslin Diabetes Center... Lipomics' Press Release-
